Hillstar Bio Announces the Formation of Clinical Advisory Board with Prominent Experts in Axial Spondyloarthritis and Autoimmune Disease Drug Development
Hillstar Bio Appoints Maude Tessier, Ph.D., as Chief Operating Officer and Expands Leadership Team to Advance Pipeline of Precision Immunotherapies
